Showing results (341-350 of 449) with videos related to

Sort By:
Pageof 45
Molecular Carcinogenesis|April 26, 2020
Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cellsKarin Toews, Laura Grunewald, Silke Schwiebert, et al.
International Journal of Cancer|May 18, 2010
Accurate prediction of neuroblastoma outcome based on miRNA expression profilesJohannes H Schulte, Benjamin Schowe, Pieter Mestdagh, et al.
Cancers|April 3, 2021
CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-StimulusAna Textor, Laura Grunewald, Kathleen Anders, et al.
Lancet (London, England)|March 28, 2021
Migraine: disease characterisation, biomarkers, and precision medicineMessoud Ashina, Gisela M Terwindt, Mohammad Al-Mahdi Al-Karagholi, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Human Molecular Genetics|August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasDaniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Lancet (London, England)|September 3, 1977
Circulating thymic-hormone activity in congenital immunodeficiencyV Lewis, J J Twomey, G Goldstein, et al.
Oncogene|March 6, 2018
LIN28B enhanced tumorigenesis in an autochthonous KRAS<sup>G12V</sup>-driven lung carcinoma mouse modelLydia Meder, Katharina König, Felix Dietlein, et al.
Pageof 45